DERM
Price
$6.25
Change
+$0.04 (+0.64%)
Updated
Apr 17 closing price
Capitalization
73.35M
23 days until earnings call
TLRY
Price
$0.45
Change
-$0.03 (-6.25%)
Updated
Apr 17 closing price
Capitalization
1.87B
94 days until earnings call
Ad is loading...

DERM vs TLRY

Header iconDERM vs TLRY Comparison
Open Charts DERM vs TLRYBanner chart's image
Journey Medical
Price$6.25
Change+$0.04 (+0.64%)
Volume$53.67K
Capitalization73.35M
Tilray Brands
Price$0.45
Change-$0.03 (-6.25%)
Volume$44.27M
Capitalization1.87B
DERM vs TLRY Comparison Chart
Loading...
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DERM vs. TLRY commentary
Apr 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DERM is a Hold and TLRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 20, 2025
Stock price -- (DERM: $6.25 vs. TLRY: $0.45)
Brand notoriety: DERM and TLRY are both notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DERM: 75% vs. TLRY: 128%
Market capitalization -- DERM: $73.35M vs. TLRY: $1.87B
DERM [@Pharmaceuticals: Other] is valued at $73.35M. TLRY’s [@Pharmaceuticals: Other] market capitalization is $1.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DERM’s FA Score shows that 0 FA rating(s) are green whileTLRY’s FA Score has 0 green FA rating(s).

  • DERM’s FA Score: 0 green, 5 red.
  • TLRY’s FA Score: 0 green, 5 red.
According to our system of comparison, DERM is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DERM’s TA Score shows that 4 TA indicator(s) are bullish while TLRY’s TA Score has 4 bullish TA indicator(s).

  • DERM’s TA Score: 4 bullish, 5 bearish.
  • TLRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than DERM.

Price Growth

DERM (@Pharmaceuticals: Other) experienced а +3.14% price change this week, while TLRY (@Pharmaceuticals: Other) price change was -10.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.78%. For the same industry, the average monthly price growth was -5.82%, and the average quarterly price growth was -13.07%.

Reported Earning Dates

DERM is expected to report earnings on Aug 12, 2025.

TLRY is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY($1.87B) has a higher market cap than DERM($73.4M). DERM YTD gains are higher at: 59.847 vs. TLRY (-66.165). DERM has higher annual earnings (EBITDA): -5.69M vs. TLRY (-1.23B). TLRY has more cash in the bank: 260M vs. DERM (24.7M). DERM has less debt than TLRY: DERM (131K) vs TLRY (529M). TLRY has higher revenues than DERM: TLRY (700M) vs DERM (79.9M).
DERMTLRYDERM / TLRY
Capitalization73.4M1.87B4%
EBITDA-5.69M-1.23B0%
Gain YTD59.847-66.165-90%
P/E RatioN/A8.52-
Revenue79.9M700M11%
Total Cash24.7M260M10%
Total Debt131K529M0%
FUNDAMENTALS RATINGS
DERM vs TLRY: Fundamental Ratings
DERM
TLRY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
3796
P/E GROWTH RATING
1..100
3993
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLRY's Valuation (49) in the Biotechnology industry is in the same range as DERM (69). This means that TLRY’s stock grew similarly to DERM’s over the last 12 months.

TLRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DERM (100). This means that TLRY’s stock grew similarly to DERM’s over the last 12 months.

TLRY's SMR Rating (96) in the Biotechnology industry is in the same range as DERM (99). This means that TLRY’s stock grew similarly to DERM’s over the last 12 months.

DERM's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for TLRY (96). This means that DERM’s stock grew somewhat faster than TLRY’s over the last 12 months.

DERM's P/E Growth Rating (39) in the Biotechnology industry is somewhat better than the same rating for TLRY (93). This means that DERM’s stock grew somewhat faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DERMTLRY
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 28 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
View a ticker or compare two or three
Ad is loading...
DERM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

DERM and

Correlation & Price change

A.I.dvisor tells us that DERM and SWGHF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DERM and SWGHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
+0.64%
SWGHF - DERM
25%
Poorly correlated
N/A
CRDL - DERM
22%
Poorly correlated
N/A
YCBD - DERM
22%
Poorly correlated
+6.68%
TLRY - DERM
21%
Poorly correlated
-5.42%
AQST - DERM
20%
Poorly correlated
+0.40%
More

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with CGC. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
-5.42%
CGC - TLRY
72%
Closely correlated
+0.85%
ACB - TLRY
68%
Closely correlated
+2.30%
CRON - TLRY
65%
Loosely correlated
N/A
OGI - TLRY
62%
Loosely correlated
+2.88%
FLGC - TLRY
30%
Poorly correlated
+11.26%
More